Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-09

FDA Approved: KERENDIA — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Kerendia (finerenone) from the original application for adults with chronic kidney disease due to type 2 diabetes mellitus. It is indicated to redu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kerendia (finerenone)

Snippet

ORIG AP for KERENDIA (FINERENONE)